UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Jensen Investment Management Inc.

Jensen Investment Management Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 24.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 727,035 shares of the healthcare conglomerate’s stock after selling 239,156 shares during the period. UnitedHealth Group makes up approximately 3.6% of Jensen Investment Management Inc.’s portfolio, making the stock its 11th largest position. Jensen Investment Management Inc.’s holdings in UnitedHealth Group were worth $425,083,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Swedbank AB purchased a new position in UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $480,903,000. Finally, Dimensional Fund Advisors LP increased its position in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.7 %

Shares of NYSE UNH traded up $10.36 during trading on Friday, hitting $615.81. 3,875,838 shares of the company traded hands, compared to its average volume of 3,660,167. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $619.80. The firm has a market capitalization of $566.72 billion, a P/E ratio of 40.12, a P/E/G ratio of 1.81 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $581.93 and a 200-day moving average price of $545.44.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the company earned $6.56 EPS. The company’s revenue was up 9.2% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Stephens lowered their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Finally, Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.